Riverside Partners Invests in Net32

RF, MedEquity and Kian Invest to Form Riverside Oral Surgery Management

October 11, 2022

Healthcare Services

RF Investment Partners led a strategic investment alongside MedEquity Capital and Kian Capital Partners to form Riverside Oral Surgery Management, LLC in partnership with Riverside Oral Surgery, LLC. The investment creates a physician-led multisite oral and maxillofacial surgery platform based in River Edge, New Jersey, intended to support affiliation growth, clinical autonomy for surgeons, and expansion across the Northeast.

The Riverside Company Invests in CRIO, Inc.

May 21, 2024

Cloud & SaaS

The Riverside Company, via its Riverside Micro-Cap Fund, has made a growth investment in CRIO, Inc., a Boston-based provider of cloud-based eSource, CTMS and regulatory-compliance software for clinical trial sites, CROs and pharmaceutical/biotech sponsors. Riverside’s capital will support accelerated product development, broader product offerings and potential strategic acquisitions as CRIO scales.

Court Square Capital Partners Makes Strategic Growth Investment in West Coast Dental

July 11, 2022

Healthcare Services

Court Square Capital Partners has made a major strategic capital investment in West Coast Dental to support the company's expansion and consolidation across California. West Coast Dental—operator of 40 multi-specialty dental and orthodontic offices—will continue to be led by CEO Dr. Payam Sohrab while founders remain investors alongside Court Square to accelerate growth and increase access to dental and orthodontic care.

Riverside Partners Invests in Syner-G Pharma Consulting

October 29, 2020

Healthcare Services

Riverside Partners, a Boston-based private equity firm, completed an investment in Syner-G Pharma Consulting, a CMC regulatory and compliance consulting firm headquartered in Southborough, Massachusetts. The partnership with Syner-G's founders aims to support the company's next stage of growth, expand customer reach, and broaden service offerings to pharmaceutical and biotechnology clients.

Arlington Capital Partners Acquires Majority Stake in Riverpoint Medical

June 27, 2019

Medical Devices

Arlington Capital Partners completed a majority growth investment in Riverpoint Medical, a Portland-based developer and manufacturer of advanced biomedical textile medical devices. The investment will support Riverpoint's plans to expand manufacturing capacity, accelerate product development across wound closure, sports medicine and animal health markets, and scale the business with existing management retaining material ownership.

Cathay Capital Invests in Parkview Dental Partners

November 6, 2023

Healthcare Services

Cathay Capital has made a strategic investment in Sarasota-based dental service organization Parkview Dental Partners, marking Cathay’s inaugural North American investment from its Growth Private Equity Fund (Small Cap IV). The transaction is a recapitalization that includes equity co-investment from Barings, a unitranche facility from Live Oak Banking Company and Barings, material rollover by Parkview management and prior owner Parkstone Growth Partners, and will fund Parkview’s buy-and-build expansion across Florida.